Skip to content

Public FDA record

Z-1382-2019: UniCel DxH 800 Coulter Cellular Analysis System, REF numbers 629029, B24465, B24802, B68304, B66445, and

Recall record Z-1382-2019 for Beckman Coulter Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1382-2019
Company in FDA record
Beckman Coulter Inc.
FDA classification date
May 23, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Complaints received of sporadic erroneously elevated platelet results without flags or system messages. Thrombocytopenia may go unrecognized.

Source facts

Action
Urgent Medical Device Recall letters, dated July 30, 2018, were sent via email and postal mail on August 1, 2018 (for those customers not on their email notification system). On 05/22/19, second Urgent Medical Device (UMDC) Recall letters, and Important Safety Information notices, dated May 20, 2019 (replacing BEC UMDC letter dated July 30, 2018), were sent via mail and/or phone and/or e-mail informing customers perform the following actions: - Run samples on an instrument not subject to this recall to confirm the platelet results. - If an alternative instrument is not available, use the following quality control measures to aid in identification of discrepant platelet results: a) Perform manual scanning/estimate of platelets on a peripheral smear and compare with instrument results. Note that this method will identify samples with marked to moderate thrombocytopenia but may not identify smaller discrepancies. b) Repeat testing of samples in a workflow configuration may facilitate the identification of discrepancies. If an erroneous result is detected, review results from adjacent samples, i.e., those tested on the instrument both before and after the erroneous result. c) Additional instrument and/or LIS features including reference ranges, XM (exponentially-weighted moving average) and delta checks may be informative. d) Follow your laboratory's standard operating procedure to confirm unexpected results. - Ongoing investigation indicates that the probable root cause is the sweep flow disruption that may occur following the "Clear RBC Apertures" procedure. This potential root cause is currently under further investigation. Customers should discontinue using this procedure. If you suspect that your instrument has a clogged aperture that will not clear, discontinue use of the analyzer, contact Customer Support Center and request service. - Communicate to the ordering physicians the need to avoid patient treatment based solely on any single test resu
Initiated
2018-07-30
Root cause
Software Design Change
Terminated
2022-03-31
Distribution
Worldwide Distribution - US Nationwide including Puerto Rico. There was government and military distribution. Foreign distribution was made to Andorra, Australia, Austria, Belgium, Canada, China, Croatia, Egypt, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Kuwait, Latvia, Lithuania, Mexico, Morocco, Myanmar, Netherlands Antilles, New Zealand, Portugal, Romania, Russia, Saudi Arabia, Serbia, Slovenia, Spain, Switzerland, Trinidad and Tobago, U.A.E, United Kingdom, and Vietnam.
Recall number
Z-1382-2019
Recall status
Terminated
CDRH record ID
171361
FDA classified
2019-05-23
Recall event number
82329

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗